CDLX vs. ONTF, INSE, HCAT, KLTR, CCRD, GDEV, GMGI, SANG, TEAD, and TRUE
Should you be buying Cardlytics stock or one of its competitors? The main competitors of Cardlytics include ON24 (ONTF), Inspired Entertainment (INSE), Health Catalyst (HCAT), Kaltura (KLTR), CoreCard (CCRD), GDEV (GDEV), Golden Matrix Group (GMGI), Sangoma Technologies (SANG), Teads (TEAD), and TrueCar (TRUE). These companies are all part of the "computer software" industry.
Cardlytics vs. Its Competitors
Cardlytics (NASDAQ:CDLX) and ON24 (NYSE:ONTF) are both small-cap computer software companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.
68.1% of Cardlytics shares are held by institutional investors. Comparatively, 83.9% of ON24 shares are held by institutional investors. 4.4% of Cardlytics shares are held by company insiders. Comparatively, 33.0% of ON24 shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, ON24 had 13 more articles in the media than Cardlytics. MarketBeat recorded 13 mentions for ON24 and 0 mentions for Cardlytics. Cardlytics' average media sentiment score of 0.00 beat ON24's score of -0.10 indicating that Cardlytics is being referred to more favorably in the media.
Cardlytics currently has a consensus price target of $2.25, suggesting a potential upside of 144.43%. ON24 has a consensus price target of $5.33, suggesting a potential downside of 3.90%. Given Cardlytics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Cardlytics is more favorable than ON24.
Cardlytics has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, ON24 has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500.
ON24 has lower revenue, but higher earnings than Cardlytics. ON24 is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.
ON24 has a net margin of -25.34% compared to Cardlytics' net margin of -68.87%. ON24's return on equity of -21.03% beat Cardlytics' return on equity.
Summary
ON24 beats Cardlytics on 9 of the 16 factors compared between the two stocks.
Get Cardlytics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CDLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cardlytics Competitors List
Related Companies and Tools
This page (NASDAQ:CDLX) was last updated on 9/5/2025 by MarketBeat.com Staff
Free CDLX Stock Alerts